The PYK2 inhibitor PF-562271 enhances the effect of temozolomide on tumor growth in a C57Bl/6-Gl261 mouse glioma model (original) (raw)
Pharmacologic blockade of FAK autophosphorylation decreases human glioblastoma tumor growth and synergizes with temozolomide
Brian Eliceiri
Molecular cancer therapeutics, 2013
View PDFchevron_right
Pyk2/FAK Signaling Is Upregulated in Recurrent Glioblastoma Tumors in a C57BL/6/GL261 Glioma Implantation Model
Mikhail Inyushin
International Journal of Molecular Sciences
View PDFchevron_right
Effect of temozolomide on the U-118 glioma cell line
Helena Carvalheiro
Oncology Letters, 2011
View PDFchevron_right
The Tyrosine Kinase Pyk2 Promotes Migration and Invasion of Glioma Cells
Michael Berens
Neoplasia, 2005
View PDFchevron_right
Involvement of PI3K Pathway in Glioma Cell Resistance to Temozolomide Treatment
Iwona Wertel
International Journal of Molecular Sciences
View PDFchevron_right
Molecular Targets: Inhibition of Tumor Cell Invasion
Silvya Stuchi Maria-Engler
Novel Therapeutic Concepts in Targeting Glioma, 2012
View PDFchevron_right
Src Inhibitors Pyrazolo[3,4-d]pyrimidines, Si306 and Pro-Si306, Inhibit Focal Adhesion Kinase and Suppress Human Glioblastoma Invasion In Vitro and In Vivo
Aleksandra Divac Rankov
Cancers, 2020
View PDFchevron_right
Extended survival of Pyk2 or FAK deficient orthotopic glioma xenografts
Michael Berens
Journal of Neuro-Oncology, 2008
View PDFchevron_right
Differential role of proline-rich tyrosine kinase 2 and focal adhesion kinase in determining glioblastoma migration and proliferation
Joseph Loftus
Molecular cancer research : MCR, 2003
View PDFchevron_right
Differential Role of Proline-Rich Tyrosine Kinase 2 and Focal Adhesion Kinase in Determining Glioblastoma Migration and Proliferation1 1 National Institutes of Health Grants HL67938 (J.C.L.) and NS42262 (M.E.B.)
Michael Berens
Molecular Cancer Research, 2003
View PDFchevron_right
Cancer- related protein profile of patient-derived and commercial glioblastoma cell lines exposed to Temozolomide
Ewa Obuchowicz
Research Square (Research Square), 2023
View PDFchevron_right
Temozolomide decreases invasion of glioma stem cells by down-regulating TGF-β2
Bo Qiu
2011
View PDFchevron_right
Prevention of irradiation-induced glioma cell invasion by temozolomide involves caspase 3 activity and cleavage of focal adhesion kinase
Johannes Dichgans
Cancer research, 2002
View PDFchevron_right
Obstacles to Glioblastoma Treatment Two Decades after Temozolomide
Carolina Batista
Cancers
View PDFchevron_right
Combination therapy in a xenograft model of glioblastoma: enhancement of the antitumor activity of temozolomide by an MDM2 antagonist
Jixin Ding
Journal of neurosurgery, 2016
View PDFchevron_right
Acquisition of temozolomide resistance by the rat C6 glioma cell line increases cell migration and side population phenotype
Jiejing Li
Oncology Reports
View PDFchevron_right
Effect of P-glycoprotein Inhibition on Temozolomide Chemosensitivity on the Neuroblastoma Cell Line Sh-sy5y
Mustafa Karademir
Research Square (Research Square), 2023
View PDFchevron_right
Glioma-associated endothelial cells are chemoresistant to temozolomide
Walavan Sivakumar
Journal of Neuro-Oncology, 2009
View PDFchevron_right
Astrocytes Decreased the Sensitivity of Glioblastoma Cells to Temozolomide and Bay 11-7082
Yasemin Akay
International Journal of Molecular Sciences
View PDFchevron_right
Matteucinol combined with temozolomide inhibits glioblastoma proliferation, invasion, and progression: an in vitro, in silico, and in vivo study
Rafael Chagas
Brazilian Journal of Medical and Biological Research
View PDFchevron_right
Glycogen Synthase Kinase 3 Sustains Invasion of Glioblastoma via the Focal Adhesion Kinase, Rac1, and c-Jun N-Terminal Kinase-Mediated Pathway
Toshinari Minamoto
Molecular Cancer Therapeutics, 2014
View PDFchevron_right
Microglial Cytokines Induce Invasiveness and Proliferation of Human Glioblastoma through Pyk2 and FAK Activation
Lilia Kucheryavykh
Cancers
View PDFchevron_right
Effects of temozolomide on U87MG glioblastoma cell expression of CXCR4, MMP2, MMP9, VEGF, anti-proliferatory cytotoxic and apoptotic properties
Amir Kiani
Molecular Biology Reports, 2020
View PDFchevron_right
FAK mediates the inhibition of glioma cell migration by truncated 24kDa FGF-2
Brian Eliceiri
Biochemical and Biophysical Research Communications, 2009
View PDFchevron_right
The Pyk2 FERM domain as a target to inhibit glioma migration
Joseph Loftus
Molecular Cancer Therapeutics, 2009
View PDFchevron_right
Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo
Dowdy Jackson
Molecular Cancer Therapeutics, 2007
View PDFchevron_right
Temozolomide Induces the Production of Epidermal Growth Factor to Regulate MDR1 Expression in Glioblastoma Cells
Jessian Munoz
Molecular Cancer Therapeutics, 2014
View PDFchevron_right
In vitro and in vivo analysis of RTK inhibitor efficacy and identification of its novel targets in glioblastomas
Joao Barata
Translational Oncology, 2013
View PDFchevron_right
Temozolomide promotes genomic and phenotypic changes in glioblastoma cells
Aleksei A Stepanenko
Cancer Cell International, 2016
View PDFchevron_right
EGFR Inhibition in Glioma Cells Modulates Rho Signaling to Inhibit Cell Motility and Invasion and Cooperates with Temozolomide to Reduce Cell Growth
jose rodriguez
PLoS ONE, 2012
View PDFchevron_right
Temozolomide in malignant gliomas: current use and future targets
Linda Bressler
Cancer Chemotherapy and Pharmacology, 2009
View PDFchevron_right